Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals

The increase in the prevalence of infections caused by certain bacteria, such as Klebsiella pneumonia ( K. pneumoniae ), is a global health concern. Bacterial production of an enzyme called extended-spectrum beta-lactamase (ESBL) can generate resistance to antimicrobial therapeutics. Therefore, betw...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Epidemiology and Global Health 2023-06, Vol.13 (2), p.180-190
Hauptverfasser: Al-Sheboul, Suhaila A., Al-Madi, Ghina S., Brown, Brent, Hayajneh, Wail A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 190
container_issue 2
container_start_page 180
container_title Journal of Epidemiology and Global Health
container_volume 13
creator Al-Sheboul, Suhaila A.
Al-Madi, Ghina S.
Brown, Brent
Hayajneh, Wail A.
description The increase in the prevalence of infections caused by certain bacteria, such as Klebsiella pneumonia ( K. pneumoniae ), is a global health concern. Bacterial production of an enzyme called extended-spectrum beta-lactamase (ESBL) can generate resistance to antimicrobial therapeutics. Therefore, between 2012 and 2013, we investigated K. pneumoniae that produce ESBLs with the prevalence of individual genes including bla SHV , bla CTX-M , bla TEM , and bla OXA isolated from clinical samples. A total of 99 variable diagnostic samples including blood from hematological malignancies ( n  = 14) or other clinical sources including sputum, pus, urine, and wound ( n  = 85) were analyzed. All samples' bacterial type was confirmed and their susceptibility to antimicrobial agents was established. Polymerase chain reaction (PCR) amplification was carried out to ascertain presence of specific genes that included bla SHV , bla CTX-M , bla TEM , and bla OXA. Plasmid DNA profiles were determined to assess significance between resistance to antimicrobial agents and plasmid number. It was found that among non-hematologic malignancy isolates, the highest rate of resistance was 87.9% to imipenem, with lowest rate being 2% to ampicillin. However, in hematologic malignancy isolates, the highest microbial resistance was 92.9% to ampicillin with the lowest rate of resistance at 28.6% to imipenem. Among collected isolates, 45% were ESBL-producers with 50% occurrence in hematologic malignancy individuals that were ESBL-producers. Within ESBL-producing isolates from hematologic malignancy individuals , bla SHV was detected in 100%, bla CTX -M in 85.7%, and bla TEM and bla OXA-1 at 57.1% and 27.1%, respectively. In addition, bla SHV, bla CTX-M , and bla OXA were found in all non-hematological malignancy individuals with bla TEM detected in 55.5% of samples. Our findings indicate that ESBLs expressing bla SHV and bla CTX-M genes are significantly prevalent in K. pneumoniae isolates from hematologic malignancy individuals. Plasmid analysis indicated plasmids in isolates collected from hematological malignancy individuals. Furthermore, there was a correlation between resistance to antimicrobial agents and plasmids within two groups analyzed. This study indicates an increase in incidence of K. pneumoniae infections displaying ESBL phenotypes in Jordan.
doi_str_mv 10.1007/s44197-023-00096-2
format Article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10272028</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_86cb5380cf374d95b46c2e8c44ae9977</doaj_id><sourcerecordid>37095370</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-c5c9d41de4cb7fd00650a359fb79d7282052da7e25f9c2558d544a4f6c9bc92d3</originalsourceid><addsrcrecordid>eNp9kU9u1TAQxiMEolXpBVigXCAwduw4XiFUlfbBQyD-rC3HnjxcJXZkOxVwLA7CmTANVO2GzcxoZr7fSPNV1VMCzwmAeJEYI1I0QNsGAGTX0AfVMaUEmg4Ie3inPqpOU3IDMCYlZ9A-ro5aAZKXcFz9-BDxWk_oDdZhrM-_ZfQWbfNpQZPjOte_fjZ7bbKedcJUO1-_W6fsbFwPzUdMLmXtc_12wiE5nCZdLx7XOXinsd6lMOm8qd6EaHXp-voypMVlPaUn1aOxJDz9m0-qL6_PP59dNvv3F7uzV_vGcNLmEo20jFhkZhCjBeg46JbLcRDSCtpT4NRqgZSP0lDOe8sZ02zsjByMpLY9qXYb1wZ9pZboZh2_q6CdummEeFA6ZmcmVH1nBt72YMZWMCv5wDpDsTcFiFIKUVgvN9ayDjNagz5HPd2D3p9491UdwrUiQAUF2hcC3QgmhpQijrdiAuqPs2pzVhVn1Y2zihbRs7tnbyX_fCwL7baQysgfMKqrsEZf3vo_7G_N2LKq</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Al-Sheboul, Suhaila A. ; Al-Madi, Ghina S. ; Brown, Brent ; Hayajneh, Wail A.</creator><creatorcontrib>Al-Sheboul, Suhaila A. ; Al-Madi, Ghina S. ; Brown, Brent ; Hayajneh, Wail A.</creatorcontrib><description>The increase in the prevalence of infections caused by certain bacteria, such as Klebsiella pneumonia ( K. pneumoniae ), is a global health concern. Bacterial production of an enzyme called extended-spectrum beta-lactamase (ESBL) can generate resistance to antimicrobial therapeutics. Therefore, between 2012 and 2013, we investigated K. pneumoniae that produce ESBLs with the prevalence of individual genes including bla SHV , bla CTX-M , bla TEM , and bla OXA isolated from clinical samples. A total of 99 variable diagnostic samples including blood from hematological malignancies ( n  = 14) or other clinical sources including sputum, pus, urine, and wound ( n  = 85) were analyzed. All samples' bacterial type was confirmed and their susceptibility to antimicrobial agents was established. Polymerase chain reaction (PCR) amplification was carried out to ascertain presence of specific genes that included bla SHV , bla CTX-M , bla TEM , and bla OXA. Plasmid DNA profiles were determined to assess significance between resistance to antimicrobial agents and plasmid number. It was found that among non-hematologic malignancy isolates, the highest rate of resistance was 87.9% to imipenem, with lowest rate being 2% to ampicillin. However, in hematologic malignancy isolates, the highest microbial resistance was 92.9% to ampicillin with the lowest rate of resistance at 28.6% to imipenem. Among collected isolates, 45% were ESBL-producers with 50% occurrence in hematologic malignancy individuals that were ESBL-producers. Within ESBL-producing isolates from hematologic malignancy individuals , bla SHV was detected in 100%, bla CTX -M in 85.7%, and bla TEM and bla OXA-1 at 57.1% and 27.1%, respectively. In addition, bla SHV, bla CTX-M , and bla OXA were found in all non-hematological malignancy individuals with bla TEM detected in 55.5% of samples. Our findings indicate that ESBLs expressing bla SHV and bla CTX-M genes are significantly prevalent in K. pneumoniae isolates from hematologic malignancy individuals. Plasmid analysis indicated plasmids in isolates collected from hematological malignancy individuals. Furthermore, there was a correlation between resistance to antimicrobial agents and plasmids within two groups analyzed. This study indicates an increase in incidence of K. pneumoniae infections displaying ESBL phenotypes in Jordan.</description><identifier>ISSN: 2210-6014</identifier><identifier>ISSN: 2210-6006</identifier><identifier>EISSN: 2210-6014</identifier><identifier>DOI: 10.1007/s44197-023-00096-2</identifier><identifier>PMID: 37095370</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Ampicillin ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; beta-Lactamases - genetics ; Extended-spectrum β-lactamases ; Hematological malignancy ; Hospitals ; Humans ; Imipenem ; Jordan ; Jordan - epidemiology ; Klebsiella pneumoniae ; Klebsiella pneumoniae - genetics ; Medicine ; Medicine &amp; Public Health ; Multidrug resistance ; Plasmid profile ; Prevalence ; Research Article</subject><ispartof>Journal of Epidemiology and Global Health, 2023-06, Vol.13 (2), p.180-190</ispartof><rights>The Author(s) 2023. corrected publication 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023, corrected publication 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-c5c9d41de4cb7fd00650a359fb79d7282052da7e25f9c2558d544a4f6c9bc92d3</citedby><cites>FETCH-LOGICAL-c513t-c5c9d41de4cb7fd00650a359fb79d7282052da7e25f9c2558d544a4f6c9bc92d3</cites><orcidid>0000-0001-5238-6943 ; 0000-0001-9001-3232 ; 0000-0003-1816-9018</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272028/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272028/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37095370$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Sheboul, Suhaila A.</creatorcontrib><creatorcontrib>Al-Madi, Ghina S.</creatorcontrib><creatorcontrib>Brown, Brent</creatorcontrib><creatorcontrib>Hayajneh, Wail A.</creatorcontrib><title>Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals</title><title>Journal of Epidemiology and Global Health</title><addtitle>J Epidemiol Glob Health</addtitle><addtitle>J Epidemiol Glob Health</addtitle><description>The increase in the prevalence of infections caused by certain bacteria, such as Klebsiella pneumonia ( K. pneumoniae ), is a global health concern. Bacterial production of an enzyme called extended-spectrum beta-lactamase (ESBL) can generate resistance to antimicrobial therapeutics. Therefore, between 2012 and 2013, we investigated K. pneumoniae that produce ESBLs with the prevalence of individual genes including bla SHV , bla CTX-M , bla TEM , and bla OXA isolated from clinical samples. A total of 99 variable diagnostic samples including blood from hematological malignancies ( n  = 14) or other clinical sources including sputum, pus, urine, and wound ( n  = 85) were analyzed. All samples' bacterial type was confirmed and their susceptibility to antimicrobial agents was established. Polymerase chain reaction (PCR) amplification was carried out to ascertain presence of specific genes that included bla SHV , bla CTX-M , bla TEM , and bla OXA. Plasmid DNA profiles were determined to assess significance between resistance to antimicrobial agents and plasmid number. It was found that among non-hematologic malignancy isolates, the highest rate of resistance was 87.9% to imipenem, with lowest rate being 2% to ampicillin. However, in hematologic malignancy isolates, the highest microbial resistance was 92.9% to ampicillin with the lowest rate of resistance at 28.6% to imipenem. Among collected isolates, 45% were ESBL-producers with 50% occurrence in hematologic malignancy individuals that were ESBL-producers. Within ESBL-producing isolates from hematologic malignancy individuals , bla SHV was detected in 100%, bla CTX -M in 85.7%, and bla TEM and bla OXA-1 at 57.1% and 27.1%, respectively. In addition, bla SHV, bla CTX-M , and bla OXA were found in all non-hematological malignancy individuals with bla TEM detected in 55.5% of samples. Our findings indicate that ESBLs expressing bla SHV and bla CTX-M genes are significantly prevalent in K. pneumoniae isolates from hematologic malignancy individuals. Plasmid analysis indicated plasmids in isolates collected from hematological malignancy individuals. Furthermore, there was a correlation between resistance to antimicrobial agents and plasmids within two groups analyzed. This study indicates an increase in incidence of K. pneumoniae infections displaying ESBL phenotypes in Jordan.</description><subject>Ampicillin</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>beta-Lactamases - genetics</subject><subject>Extended-spectrum β-lactamases</subject><subject>Hematological malignancy</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Imipenem</subject><subject>Jordan</subject><subject>Jordan - epidemiology</subject><subject>Klebsiella pneumoniae</subject><subject>Klebsiella pneumoniae - genetics</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Multidrug resistance</subject><subject>Plasmid profile</subject><subject>Prevalence</subject><subject>Research Article</subject><issn>2210-6014</issn><issn>2210-6006</issn><issn>2210-6014</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNp9kU9u1TAQxiMEolXpBVigXCAwduw4XiFUlfbBQyD-rC3HnjxcJXZkOxVwLA7CmTANVO2GzcxoZr7fSPNV1VMCzwmAeJEYI1I0QNsGAGTX0AfVMaUEmg4Ie3inPqpOU3IDMCYlZ9A-ro5aAZKXcFz9-BDxWk_oDdZhrM-_ZfQWbfNpQZPjOte_fjZ7bbKedcJUO1-_W6fsbFwPzUdMLmXtc_12wiE5nCZdLx7XOXinsd6lMOm8qd6EaHXp-voypMVlPaUn1aOxJDz9m0-qL6_PP59dNvv3F7uzV_vGcNLmEo20jFhkZhCjBeg46JbLcRDSCtpT4NRqgZSP0lDOe8sZ02zsjByMpLY9qXYb1wZ9pZboZh2_q6CdummEeFA6ZmcmVH1nBt72YMZWMCv5wDpDsTcFiFIKUVgvN9ayDjNagz5HPd2D3p9491UdwrUiQAUF2hcC3QgmhpQijrdiAuqPs2pzVhVn1Y2zihbRs7tnbyX_fCwL7baQysgfMKqrsEZf3vo_7G_N2LKq</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Al-Sheboul, Suhaila A.</creator><creator>Al-Madi, Ghina S.</creator><creator>Brown, Brent</creator><creator>Hayajneh, Wail A.</creator><general>Springer Netherlands</general><general>Springer</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5238-6943</orcidid><orcidid>https://orcid.org/0000-0001-9001-3232</orcidid><orcidid>https://orcid.org/0000-0003-1816-9018</orcidid></search><sort><creationdate>20230601</creationdate><title>Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals</title><author>Al-Sheboul, Suhaila A. ; Al-Madi, Ghina S. ; Brown, Brent ; Hayajneh, Wail A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-c5c9d41de4cb7fd00650a359fb79d7282052da7e25f9c2558d544a4f6c9bc92d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Ampicillin</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>beta-Lactamases - genetics</topic><topic>Extended-spectrum β-lactamases</topic><topic>Hematological malignancy</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Imipenem</topic><topic>Jordan</topic><topic>Jordan - epidemiology</topic><topic>Klebsiella pneumoniae</topic><topic>Klebsiella pneumoniae - genetics</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Multidrug resistance</topic><topic>Plasmid profile</topic><topic>Prevalence</topic><topic>Research Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Sheboul, Suhaila A.</creatorcontrib><creatorcontrib>Al-Madi, Ghina S.</creatorcontrib><creatorcontrib>Brown, Brent</creatorcontrib><creatorcontrib>Hayajneh, Wail A.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of Epidemiology and Global Health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Sheboul, Suhaila A.</au><au>Al-Madi, Ghina S.</au><au>Brown, Brent</au><au>Hayajneh, Wail A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals</atitle><jtitle>Journal of Epidemiology and Global Health</jtitle><stitle>J Epidemiol Glob Health</stitle><addtitle>J Epidemiol Glob Health</addtitle><date>2023-06-01</date><risdate>2023</risdate><volume>13</volume><issue>2</issue><spage>180</spage><epage>190</epage><pages>180-190</pages><issn>2210-6014</issn><issn>2210-6006</issn><eissn>2210-6014</eissn><abstract>The increase in the prevalence of infections caused by certain bacteria, such as Klebsiella pneumonia ( K. pneumoniae ), is a global health concern. Bacterial production of an enzyme called extended-spectrum beta-lactamase (ESBL) can generate resistance to antimicrobial therapeutics. Therefore, between 2012 and 2013, we investigated K. pneumoniae that produce ESBLs with the prevalence of individual genes including bla SHV , bla CTX-M , bla TEM , and bla OXA isolated from clinical samples. A total of 99 variable diagnostic samples including blood from hematological malignancies ( n  = 14) or other clinical sources including sputum, pus, urine, and wound ( n  = 85) were analyzed. All samples' bacterial type was confirmed and their susceptibility to antimicrobial agents was established. Polymerase chain reaction (PCR) amplification was carried out to ascertain presence of specific genes that included bla SHV , bla CTX-M , bla TEM , and bla OXA. Plasmid DNA profiles were determined to assess significance between resistance to antimicrobial agents and plasmid number. It was found that among non-hematologic malignancy isolates, the highest rate of resistance was 87.9% to imipenem, with lowest rate being 2% to ampicillin. However, in hematologic malignancy isolates, the highest microbial resistance was 92.9% to ampicillin with the lowest rate of resistance at 28.6% to imipenem. Among collected isolates, 45% were ESBL-producers with 50% occurrence in hematologic malignancy individuals that were ESBL-producers. Within ESBL-producing isolates from hematologic malignancy individuals , bla SHV was detected in 100%, bla CTX -M in 85.7%, and bla TEM and bla OXA-1 at 57.1% and 27.1%, respectively. In addition, bla SHV, bla CTX-M , and bla OXA were found in all non-hematological malignancy individuals with bla TEM detected in 55.5% of samples. Our findings indicate that ESBLs expressing bla SHV and bla CTX-M genes are significantly prevalent in K. pneumoniae isolates from hematologic malignancy individuals. Plasmid analysis indicated plasmids in isolates collected from hematological malignancy individuals. Furthermore, there was a correlation between resistance to antimicrobial agents and plasmids within two groups analyzed. This study indicates an increase in incidence of K. pneumoniae infections displaying ESBL phenotypes in Jordan.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>37095370</pmid><doi>10.1007/s44197-023-00096-2</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-5238-6943</orcidid><orcidid>https://orcid.org/0000-0001-9001-3232</orcidid><orcidid>https://orcid.org/0000-0003-1816-9018</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2210-6014
ispartof Journal of Epidemiology and Global Health, 2023-06, Vol.13 (2), p.180-190
issn 2210-6014
2210-6006
2210-6014
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10272028
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Springer Nature OA Free Journals; PubMed Central; SpringerLink Journals - AutoHoldings
subjects Ampicillin
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
beta-Lactamases - genetics
Extended-spectrum β-lactamases
Hematological malignancy
Hospitals
Humans
Imipenem
Jordan
Jordan - epidemiology
Klebsiella pneumoniae
Klebsiella pneumoniae - genetics
Medicine
Medicine & Public Health
Multidrug resistance
Plasmid profile
Prevalence
Research Article
title Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A58%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Extended-Spectrum%20%CE%B2-Lactamases%20in%20Multidrug-Resistant%20Klebsiella%20pneumoniae%20Isolates%20in%20Jordanian%20Hospitals&rft.jtitle=Journal%20of%20Epidemiology%20and%20Global%20Health&rft.au=Al-Sheboul,%20Suhaila%20A.&rft.date=2023-06-01&rft.volume=13&rft.issue=2&rft.spage=180&rft.epage=190&rft.pages=180-190&rft.issn=2210-6014&rft.eissn=2210-6014&rft_id=info:doi/10.1007/s44197-023-00096-2&rft_dat=%3Cpubmed_doaj_%3E37095370%3C/pubmed_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37095370&rft_doaj_id=oai_doaj_org_article_86cb5380cf374d95b46c2e8c44ae9977&rfr_iscdi=true